We are live on ! Find out more
VBIO

Valion Bio
VBIO

1 hedge funds and large institutions have $492K invested in Valion Bio in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1.31% more ownership

Funds ownership: 0% → 1.31% (+1.3%)

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
+$183K

Top Sellers

No sellers this quarter

VBIO Hedge Fund Activity: Q4 2021 in Review

1 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Valion Bio (VBIO) for Q4 2021, worth a combined $492K.

Buyers outnumbered sellers: 1 fund opened new VBIO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Kepos Capital, opening a new position worth an estimated $183K.

  • 1 institutional investor held Valion Bio (VBIO) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $492K of Valion Bio stock for Q4 2021.
  • 1 fund opened new Valion Bio positions in Q4 2021 and 0 closed out, a net change of +1 holder.
  • The largest Valion Bio buyer in Q4 2021 was Kepos Capital, an estimated $183K added.

Based on aggregated 13F filings for Q4 2021.